Vincent Cottin

1996–2026 年に発表

337
論文数
59,026
被引用数
113
h 指数
317
i10 指数

被引用数

Vincent Cottin の年別被引用数1997 年: 被引用 2 件2000 年: 被引用 6 件2001 年: 被引用 4 件2002 年: 被引用 15 件2003 年: 被引用 21 件2004 年: 被引用 20 件2005 年: 被引用 18 件2006 年: 被引用 25 件2007 年: 被引用 40 件2008 年: 被引用 37 件2009 年: 被引用 50 件2010 年: 被引用 72 件2011 年: 被引用 79 件2012 年: 被引用 123 件2013 年: 被引用 171 件2014 年: 被引用 213 件2015 年: 被引用 350 件2016 年: 被引用 366 件2017 年: 被引用 416 件2018 年: 被引用 482 件2019 年: 被引用 1,886 件2020 年: 被引用 2,354 件2021 年: 被引用 2,640 件2022 年: 被引用 2,255 件2023 年: 被引用 1,696 件2024 年: 被引用 2,978 件2025 年: 被引用 1,198 件2026 年: 被引用 36 件1998〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,591 件、この内訳の 20.9%中国: 引用元論文 1,406 件、この内訳の 8.2%イギリス: 引用元論文 1,372 件、この内訳の 8%フランス: 引用元論文 1,162 件、この内訳の 6.7%イタリア: 引用元論文 1,106 件、この内訳の 6.4%ドイツ: 引用元論文 1,077 件、この内訳の 6.3%日本: 引用元論文 912 件、この内訳の 5.3%カナダ: 引用元論文 692 件、この内訳の 4%オランダ: 引用元論文 585 件、この内訳の 3.4%オーストラリア: 引用元論文 501 件、この内訳の 2.9%スペイン: 引用元論文 481 件、この内訳の 2.8%スイス: 引用元論文 404 件、この内訳の 2.3%
0%20.9%その他 22.8%

分野

  • Medicine89.8%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Immunology and Microbiology2%
  • Engineering0.8%
  • Environmental Science0.4%
  • Neuroscience0.2%
  • その他1.2%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis18.2%
  • Pulmonary Hypertension Research and Treatments6.3%
  • Systemic Sclerosis and Related Diseases5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4%
  • Inflammatory Myopathies and Dermatomyositis3.3%
  • Sarcoidosis and Beryllium Toxicity Research3.2%
  • その他60%

共著者

全論文

検索で開く
  1. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 4,611

  2. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 4,100

  3. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 2,346

  4. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 被引用: 4,273

  5. Spectrum of Fibrotic Lung Diseases

    著者: , - New England Journal of Medicine 2020 被引用: 721

  6. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 1,444

  7. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , - The Lancet Respiratory Medicine 2019 被引用: 630

  8. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Blaas, Benjamin Bondue, Francesco Bonella, E. James Britt, Ketan Buch, John R. Burk, Hourong Cai, André M. Cantin, D.M. Castillo Villegas, Agustina Díaz Cazaux, Stefania Cerri, Said Chaaban, Nazia Chaudhuri, Vincent Cottin, Bruno Crestani, Gerard J. Criner, Caroline Dahlqvist, Sonye K. Danoff, J. Dematte D'Amico, Daniel F. Dilling, Paulo Eduardo Elias, Neil Ettinger, Jeremy Falk, Evans R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, Alex H. Gifford, Marilyn K. Glassberg, Craig S. Glazer, Jeffrey A. Golden, Luis Gómez Carrera, Julien Guiot, Robert W. Hallowell, Hiroki Hayashi, J. Hetzel, Nik Hirani, L. Homik, Benjamin Hope-Gill, David Hotchkin, Kazuya Ichikado, M. M. Ilkovich, Yoshikazu Inoue, Shinyu Izumi, Ewa Jassem, Leonie Jones, S. Jouneau, Robert J. Kaner, Jian Kang, Tsuyoshi Kawamura, Romain Kessler, Y. Kim, Kazuma Kishi, Hideya Kitamura, Martin Kolb, Yasuhiro Kondoh, Chiyoko Kono, Dirk Koschel, Michael Kreuter, Tejaswini Kulkarni, Jan Kuś, F. Lebargy, Antonio León Jiménez, Qun Luo, Yolanda Mageto, Toby M. Maher, Shigeki Makino, S. Marchand‐Adam, Charles‐Hugo Marquette, Raquel Martínez, Martin Ulises Gutierrez Martinez ほか 68 名 - The Lancet Respiratory Medicine 2020 被引用: 559

  9. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , - New England Journal of Medicine 2022 被引用: 217

  10. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 被引用: 502

  11. Progressive pulmonary fibrosis: an expert group consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 被引用: 233

  12. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

    著者: , , , , , , , , , , - European Respiratory Review 2018 被引用: 653

  13. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    著者: , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2015 被引用: 1,092

  14. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

    著者: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 346

  15. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamera J. Corte, Ian Glaspole, Nicole Goh, Mark Holmes, M.A. Malouf, Francis Thien, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Antoine Froidure, Hans Slabbynck, Wim Wuyts, Claudia Cartagena Salinas, Rosa Feijoó Seoane, Victor D. Martínez, Roxana Maturana, Juana Pavie Gallegos, Andrés Rosenblüt, Rafael Silva, Alvaro Undurraga Pereira, Martina Doubková, Norbert Pauk, Martina Plačková, Martina Šterclová, Elisabeth Bendstrup, Saher Burhan Shaker, Ingrid Louise Titlestad, Stephan Budweiser, Christian Grohé, Dirk Koschel, Michael Kreuter, Antje Prasse, Michael Weber, Hubert Wirtz, Κατερίνα Αντωνίου, Zoe Daniil, Mina Gaga, Despoina Papakosta, Shinyu Izumi, Masaki Okamoto, Alfredo Guerreros Benavides, Carlos Barrera, Alejandro Manuel Peña Villalobos, Aranzazu Campo Ezquibela, José M. Cifrián, Estrella Fernández Fabrellas, Virginia Leiro, María Molina‐Molina, Asunción Nieto Barbero, Jacobo Sellarés, Claudia Valenzuela, Shih-Lung Cheng, Ping‐Hung Kuo, Kang‐Yun Lee, Chau‐Chyun Sheu, Hakan Günen, Nesrin Moğulkoç, Sibel Naycı, Huzaifa Adamali, Stephen Bianchi, Nazia Chaudhuri, Michael Gibbons, Simon P. Hart, Philip L. Molyneaux, Helen Parfrey, Gauri Saini, Lisa Spencer, Sarah Wiscombe, Danielle Antin‐Ozerkis, Rebecca Bascom ほか 152 名 - JAMA 2023 被引用: 127

  16. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2023 被引用: 298

  17. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

    著者: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 被引用: 198

  18. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 被引用: 1,387

  19. Fibrosing interstitial lung diseases: knowns and unknowns

    著者: , , , , , - European Respiratory Review 2019 被引用: 338

  20. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 被引用: 700

  21. The Lung in Rheumatoid Arthritis

    著者: , , , , - Arthritis & Rheumatology 2018 被引用: 299

  22. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 被引用: 280

  23. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Athol U. Wells - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 226

  24. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

    著者: , , , , , , , , , , , , , , - European Respiratory Journal 2020 被引用: 218